Vidac Pharma shares encouraging early results from a Phase 2a trial for a rare skin cancer, cutaneous T-cell lymphoma, using its primary drug candidate, VDA-1102.

Azithromycin, a small molecule drug, works by targeting the 50S subunit of the bacterial ribosome and disrupting protein synthesis, ultimately leading to bacterial death.

Asieris Debuts Preliminary Results from Study on APL-1202 Pill Paired with Immune Checkpoint Blocker Tislelizumab for Pre-Surgical Care in Advanced Urinary Bladder Tumors at ASCO-GU 2024 Event.

Amitriptyline Hydrochloride, a small molecule drug, is a reuptake inhibitor targets the monoamine transporters.

Celltrion USA has finalized its application for a biosimilar approval, targeting CT-P47, a counterpart to the drug ACTEMRA® (tocilizumab).

Diclofenac Sodium, a minuscule molecule drug, wields its prowess by targeting the COX enzyme as an inhibitor.

European Commission Sanctions Takeda's HYQVIA® for Ongoing Treatment in Chronic Inflammatory Demyelinating Polyneuropathy Cases.

The powerful intelligence alert function of the Patsnap Synapse database makes it easy for you to complete various monitoring tasks.

U.S. authorities expedite assessment of ENHERTU® for individuals suffering from advanced solid cancers with HER2-positive status.

Methylprednisolone is a perplexing small molecule drug that targets both the NMDA receptor as a modulator and the glucocorticoid receptor as an agonist.

Nivolumab plus hyaluronidase administered beneath the skin is comparably effective to Opdivo given intravenously for advanced or metastatic clear cell kidney cancer as suggested by study CheckMate -67T.

Propranolol Hydrochloride, a small molecule drug, targets the β-adrenoceptors as an antagonist, exhibiting an assortment of therapeutic effects.